Evogene Ltd (NYSE:EVGN)

9.49
Delayed Data
As of May 21
 -0.01 / -0.11%
Today’s Change
8.07
Today|||52-Week Range
17.30
+3.04%
Year-to-Date

Today’s Trading

Previous close9.50
Today’s open9.65
Day’s range-- - --
Volume2,920
Average volume (3 months)6,473
Market cap$240.9M
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)-28.89%
Earnings growth (this year)-23.35%
Earnings growth (next 5 years)--
Revenue growth (last year)-17.46%
P/E ratio--
Price/Sales16.06
Price/Book2.07

Competitors

 Today’s
change
Today’s
% change
IKNXIkonics Corp0.000.00%
CCMPCabot Microelectroni...-0.48-1.02%
KYTHKYTHERA Biopharmaceu...-1.71-3.35%
OCIPOCI Partners LP-0.15-0.87%
Data as of 05/21/2015

Financials

Last reporting dateMay 19, 2015
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$14.5M
Annual profit (last year)-$14.5M
Net profit margin-100.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Financial Officer
Sigal Fattal
Corporate headquarters
Rehovot, Tel Aviv

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers